The prevalence of IgG and IgA antibodies to Chlamydia pneumoniae was evaluated in a group of an apparently healthy population in northern Greece. Serum samples were obtained over a period of one year (June 2006 to May 2007) from 530 individuals (300 males and 230 females, aged from 1 month to 90 years). The sera were tested for specific antibodies to C. pneumoniae by two commercial methods, an ELISA and a micro-IF assay based on the principles of MIF. The prevalence of IgG and IgA antibodies to C. pneumoniae was 53.2% and 45.9%, respectively, and was found to be unrelated to gender, even in the elderly >61 years old. The IgG antibody prevalence was low in children under 5 years old (7.7%), sharply increased by the age of 20 (40%) and continued to increase, gradually, to reach 80.1% in the elderly. IgA antibodies also increased with similar kinetics to IgG, although at a lower level (3.8-66.1 %). Our results show that infection with C.pneumoniae is common in northern Greece. The high prevalence of IgA specific antibodies reported in the present study is due to primary infection at a young age, while in the elderly is probably due to infection or reinfection, although the option of persistence cannot be excluded.
Chlamydia pneumoniae are Gram-negative intracellular bacteria, responsible for acute upper and lower respiratory tract infections (I). Most respiratory infections appear to be mild or asymptomatic but it can also cause severe clinical disease (2) . It has been estimated that C. pneumoniae causes about 6%-22% of community-acquired pneumonia in adults and children, varying with the geographical location and diagnostic methods used (3) . Similar to other chlamydia, C. pneumoniae often persists after acute infection, intriguing scientific interest on its possible involvement in chronic respiratory diseases, such as chronic obstructive pulmonary disease and asthma, as well as in chronic non-respiratory diseases such as atherosclerosis (4) (5) (6) . Transmission is believed to be from person-to-person contact via respiratory droplets (I). Although initially, the bacterium was considered to be a human pathogen, several later studies demonstrated that it could also infect a variety of animal species, including koalas, horses, frogs and reptiles (7) .
The objective of the present study is to provide epidemiological data on the age and gender distribution of C. pneumoniae infection in northern Greece. IgG and IgA antibody prevalence were determined, since these two antibody classes have different characteristics, IgA antibodies have not been included in most epidemiological studies and, additionally, they have been considered in many studies a better marker than IgG in chronic infections.
MATERIALS AND METHODS

Study population
Serum samples were obtained over a period of one year (June 2006 to May 2007) from 530 apparently healthy individuals (age range, I month to 90 years, 318 males and 212 females), and screened for the presence of IgG and IgA antibodies to C. pneumoniae. The study group was selected from the general population living in rural and urban areas of northern Greece and consisted of persons who had attended the hospital for an annual check up (78), blood donors (184), women tested before and during pregnancy (50), and patients attending the paediatric (81) and surgery (137) departments, all without any clinical sign of respiratory infection. All participants were divided into nine age groups: 0-6 months, 7 months-5 years, 6-10, 11-20, 21-30, 31-40, 41-50, 51-60 and >61 years. Serum samples were stored at -70°C until testing.
Detection ofspecific antibodies
Serum IgG and IgA antibodies to C. pneumoniae were assayed using an enzyme-linked immunosorbent assay, ELISA, and a microimmunofluorescence assay (based on the principles of MIF). Both kits (SeroCp, SeroFIA, Savyon Diagnostics Ltd, Israel) contain purified C. pneumoniae elementary bodies (TWI83) as antigen and include negative and positive controls. The tests were performed according to the recommendations of the manufacturer. By the ELISA assay, a serum was considered positive when the cut-off index (COl) was > 1.1. ELISA assay was evaluated against an in-house MIF test by the manufacturer. The sensitivity for testing IgG and IgA antibodies was 95% and 98%, respectively, and the specificity for both was 97%. For the MIF assay, a serum was considered positive by the appearance of a moderate to intense, sharp or diffused, apple green fluorescence, in a titer>64. The sensitivity of the MIF was evaluated to be 100% and the specificity 96.7%.
The two methods were performed independently by two expert technicians.
Statistics
The appropriate sample size was calculated using the Win Episeope 2 statistical programme (http:// www.c1ive.cd.ac.uk). The error was estimated to be 5%, the expected value of IgG antibodies 42%, and the level ofconfidence 97.5%. On the basis that the total population of northern Greece is 2,800,000, a minimum of 487 had to be involved in the study. The various percentages were compared using the x 2-test. A p value <0.05 was considered to be significant. Statistical analysis was performed by means of the SPSS vs. 15 .0 (SPSS inc).
RESULTS
The seroprevalence of IgG and IgA antibodies to C. pneumoniae in the healthy individuals studied was 53.2% and 45.9%, respectively (Table I) . All sera but two with IgA antibodies also had specific IgG antibodies. In the age group of 0-6 months, seropositivity to IgG specific antibodies was 33.3%, delineating maternal origin immunity, while IgA antibodies were not detected in any newborn. In the next age group of 7 months-5 years seropositivity was found to be 7.7% for IgG and 3.8% for IgA antibodies. At the beginning of school age (6-10 years) the IgG and IgA antibody frequency highly increased to 19.6% and 17.4%, reaching 39.7% and 31 % in the next age group 11-20 years (p=O.003, p=0.006). The prevalence continued to increase and in the age group of 51-60 years, IgG and IgA antibody frequency gradually rose to 65.7% and 58.6%, respectively, to reach in the elderly group >61 years, 80.1 % and 66.1 %, respectively.
As far as gender is concerned, 300 males (56.6%) and 230 females (43.4%) participated in the study. The IgG and IgA prevalence was higher in males than females (56.3%, 48.7% and 48.3%, 40.4%, respectively), but the difference was not statistically significant (p=0.065 and p=0.059). Even in the age group >61 years, the IgG and IgA antibody prevalence between the two sexes remained insignificant (p=0.065 and p=0.068) (Table II) .
Most of the C. pneumoniae seroepidemiological studies were carried out by MIF since it is considered the "gold standard" assay. However, it is subjective and needs highly expert technicians, thus we additionally used ELISA which is more standardised and therefore less subjective. The two assays used showed a high agreement rate.
DISCUSSION
The prevalence of antibodies to C. pneumoniae has been reported to vary depending on age, gender and region of residence of the population examined (1). The present study shows that 53.2% of the population examined had IgG antibodies pneumoniae antibodies (42%) was found in Alaskan Eskimos, a fact that was attributed to the sparse population density (17) . The age distribution in this study shows an increase ofIgG levels from 7.7% in children aged 7 months -5 years to 80.1% in the elderly >61 years, a pattern that has been generally reported in the bibliography (1). It seems that primary infection in children under 5 years of age is very rare in northern Greece, since a very low percentage of this age group have serologic evidence of past infection. The prevalence, then, increases significantly and by the age of 20, about 40% of the studied population have detectable antibody levels. These results show that primary infection mainly appears in young children and adolescents and are slightly lower than those reported in northern European countries and North America. In contrast, our results show much lower prevalence than those reported in studies from tropical countries such as Panama and Taiwan (18) . The prevalence continues to gradually increase in adults, reaching 80.1% in >61 years old. These high antibody rates in the older age groups might be a result of infection and re-infection, as Grayston has reported, a phenomenon not observed in C. trachomatis, where antibody prevalence falls off sharply after the age of 40-50 (19) . However, Volanen et al. reported that re-infection is also observed in young age, between 5 and 8 years old (20) . All serum samples were tested for IgG and IgA antibodies to C. pneumoniae simultaneously. This study showed that 45.9% of the population had IgA antibodies to C. pneumoniae. The pattern of IgA antibody age distribution shows a parallel rise to that of IgG antibodies, but in lower rates (3.8% -66.1%). A significant rise of the prevalence can be observed from the age group of 7 months -5 years (3.8%) until the end of adolescence (31%). In the same age group Tuuminen et aI., in Finland (21), reported an abrupt rise reaching 57%, although in the group of 21-30 years, the percentage dropped to 35% and started rising again to reach 85% in the >65 age group. The high frequency of IgA antibodies, especially in old age (66.1%), has not yet been clarified. It can be attributed to primary infections or re-infections, but persistence remains a possible option. Saikku had suggested that elevated levels of IgA antibodies were good markers for chronic or persistent C. pneumoniae infection (22) , whereas, following a workshop on the standardization of C. pneumoniae diagnostic methods, guidelines were published discouraging the use of IgA antibody for determining chronic infection (23) . However, several recent studies testing IgA antibodies to C. pneumoniae have suggested an association with chronic diseases (24) (25) .
C. pneumoniae seropositivity has been related to gender (1) and several theories support this hypothesis, such as male exposure to the infection outside home, smoking habits and increased male iron levels predisposing to infection (26) . The gender distribution in this study showed a tendency to higher prevalence rates of IgG and IgA antibodies in males than in females, which was stronger in the elderly, however still not statistically significant, with results similar to those of other studies (8, 27) .
There has been a correlation of C. pneumoniae infection with smoking (28) but unfortunately, information about the smoking habits of the studied population was not obtained. The presence of IgM antibodies which could provide information regarding acute infection and could probably explain the high prevalence of IgA antibodies was not evaluated. Despite these omissions, we believe that our data could comprise true baseline seroprevalence rates and age-related trends.
Concluding, halfofthe general population (53.2%) has C.pneumoniae IgG antibodies, which means that infection is as common in northern Greece as it is in the rest of Europe and North America. A number of infections occur in childhood and adolescence, and by the age of 20 a large part of the population (40%) is infected by the microorganism, while in the elderly infections or reinfections are common, since IgG antibodies prevalence rises to 80.1%. 45.9% of the general population had IgA antibodies similar to IgG antibody patterns. This high prevalence of IgA specific antibodies reported in the present study is due to primary infection in young age, while in the elderly it is probably due to infection, re-infection or persistence, although further evaluation is needed.
